BNP Paribas Discount Zert MRNA 30.../ DE000PZ0ULF5 /
8/5/2024 7:20:17 PM | Chg.-0.870 | Bid7:35:42 PM | Ask7:35:42 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
59.950EUR | -1.43% | 60.280 Bid Size: 1,800 |
60.380 Ask Size: 1,800 |
Moderna Inc | - USD | 12/30/2024 | Call |
GlobeNewswire
6/13
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
6/5
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
GlobeNewswire
5/22
Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...
GlobeNewswire
5/12
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...
GlobeNewswire
5/8
CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
5/8
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire
5/2
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/1
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems